Patent · US Active

Quinoline derivatives and their use as tyrosine kinase inhibitors

US8557843B2 · kind B2 · utility

1Cited by

1References

6Claims

0Family size

Assignee

Clanotech AB · SE

Inventors

Jacob Westman · Järlåsa, SE
Natalia Nekhotiaeva · Solna, SE
Johan Wannberg · Uppsala, SE
Ulrika Backman · Uppsala, SE
Johan Malm · Älta, SE

Key dates

Filing date	Nov 14, 2008
Grant date	Oct 15, 2013
Priority date	—
Expiry date	Nov 21, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I)as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition having a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema or psoriasis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.